1. Newton, Kim. 2015. RIPK1 and RIPK3: critical regulators of inflammation and cell death. In Trends in cell biology, 25, 347-53. doi:10.1016/j.tcb.2015.01.001. https://pubmed.ncbi.nlm.nih.gov/25662614/
2. Zhang, Xufei, Wu, Jie, Liu, Qinjie, Zhao, Yun, Ren, Jianan. . RIPK3-MLKL necroptotic signalling amplifies STING pathway and exacerbates lethal sepsis. In Clinical and translational medicine, 13, e1334. doi:10.1002/ctm2.1334. https://pubmed.ncbi.nlm.nih.gov/37475188/
3. Park, Han-Hee, Kim, Hwa-Ryeon, Park, Sang-Yeong, Roe, Jae-Seok, Kim, You-Sun. 2021. RIPK3 activation induces TRIM28 derepression in cancer cells and enhances the anti-tumor microenvironment. In Molecular cancer, 20, 107. doi:10.1186/s12943-021-01399-3. https://pubmed.ncbi.nlm.nih.gov/34419074/
4. Xie, Yadong, Zhao, Yifan, Shi, Lei, Li, Huabin, Xiao, Hui. . Gut epithelial TSC1/mTOR controls RIPK3-dependent necroptosis in intestinal inflammation and cancer. In The Journal of clinical investigation, 130, 2111-2128. doi:10.1172/JCI133264. https://pubmed.ncbi.nlm.nih.gov/31961824/
5. Karki, Rajendra, Sundaram, Balamurugan, Sharma, Bhesh Raj, Vogel, Peter, Kanneganti, Thirumala-Devi. . ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis. In Cell reports, 37, 109858. doi:10.1016/j.celrep.2021.109858. https://pubmed.ncbi.nlm.nih.gov/34686350/
6. Weindel, Chi G, Martinez, Eduardo L, Zhao, Xiao, Patrick, Kristin L, Watson, Robert O. 2022. Mitochondrial ROS promotes susceptibility to infection via gasdermin D-mediated necroptosis. In Cell, 185, 3214-3231.e23. doi:10.1016/j.cell.2022.06.038. https://pubmed.ncbi.nlm.nih.gov/35907404/
7. Snyder, Annelise G, Hubbard, Nicholas W, Messmer, Michelle N, Baker, David, Oberst, Andrew. . Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity. In Science immunology, 4, . doi:10.1126/sciimmunol.aaw2004. https://pubmed.ncbi.nlm.nih.gov/31227597/
8. Zhang, Ting, Yin, Chaoran, Fedorov, Aleksandr, Herbert, Alan, Balachandran, Siddharth. 2022. ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis. In Nature, 606, 594-602. doi:10.1038/s41586-022-04753-7. https://pubmed.ncbi.nlm.nih.gov/35614224/
9. Xu, Yue, Lin, Feng, Liao, Guolei, Chen, Wenli, Zhang, Lei. 2024. Ripks and Neuroinflammation. In Molecular neurobiology, 61, 6771-6787. doi:10.1007/s12035-024-03981-4. https://pubmed.ncbi.nlm.nih.gov/38349514/
智鼠故事 
